Variables . | Hazard ratio . | 95% confidence interval . | P-value . |
---|---|---|---|
Digitalis | 1.65 | 1.14–2.39 | 0.01 |
Male gender | 2.01 | 1.21–3.33 | 0.01 |
Age (per year) | 1.04 | 1.01–1.06 | <0.001 |
NYHA classification | 2.02 | 1.61–2.53 | <0.001 |
QRS duration ≥120 ms | 1.50 | 1.02–2.23 | 0.04 |
Variables . | Hazard ratio . | 95% confidence interval . | P-value . |
---|---|---|---|
Digitalis | 1.65 | 1.14–2.39 | 0.01 |
Male gender | 2.01 | 1.21–3.33 | 0.01 |
Age (per year) | 1.04 | 1.01–1.06 | <0.001 |
NYHA classification | 2.02 | 1.61–2.53 | <0.001 |
QRS duration ≥120 ms | 1.50 | 1.02–2.23 | 0.04 |
NYHA, New York Heart Association; CRT-D, cardiac resynchronization therapy-defibrillator.
Variables . | Hazard ratio . | 95% confidence interval . | P-value . |
---|---|---|---|
Digitalis | 1.65 | 1.14–2.39 | 0.01 |
Male gender | 2.01 | 1.21–3.33 | 0.01 |
Age (per year) | 1.04 | 1.01–1.06 | <0.001 |
NYHA classification | 2.02 | 1.61–2.53 | <0.001 |
QRS duration ≥120 ms | 1.50 | 1.02–2.23 | 0.04 |
Variables . | Hazard ratio . | 95% confidence interval . | P-value . |
---|---|---|---|
Digitalis | 1.65 | 1.14–2.39 | 0.01 |
Male gender | 2.01 | 1.21–3.33 | 0.01 |
Age (per year) | 1.04 | 1.01–1.06 | <0.001 |
NYHA classification | 2.02 | 1.61–2.53 | <0.001 |
QRS duration ≥120 ms | 1.50 | 1.02–2.23 | 0.04 |
NYHA, New York Heart Association; CRT-D, cardiac resynchronization therapy-defibrillator.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.